Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumihiro Sanada

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 8, 2010
[Therapeutic angiogenesis for diabetes mellitus related ischemic disease]Yoshiaki Taniyama, Fumihiro Sanada, Ryuichi Morishita
Frontiers in Cardiovascular Medicine|July 16, 2025
Targeting the hallmarks of aging: mechanisms and therapeutic opportunitiesFumihiro Sanada, Shinichiro Hayashi, Ryuichi Morishita
Hypertension (Dallas, Tex. : 1979)|August 11, 2020
Progress of Gene Therapy in Cardiovascular DiseaseMunehisa Shimamura, Hironori Nakagami, Fumihiro Sanada, et al.
Annals of Vascular Diseases|June 30, 2020
Therapeutic Angiogenesis Using HGF PlasmidFumihiro Sanada, Tatsuya Fujikawa, Kana Shibata, et al.
Scientific Reports|March 10, 2017
Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in MiceJun Muratsu, Masaaki Iwabayashi, Fumihiro Sanada, et al.
Frontiers in Cardiovascular Medicine|March 23, 2018
Source of Chronic Inflammation in AgingFumihiro Sanada, Yoshiaki Taniyama, Jun Muratsu, et al.
Medicines (Basel, Switzerland)|March 31, 2018
Gene-Therapeutic Strategies Targeting Angiogenesis in Peripheral Artery DiseaseFumihiro Sanada, Yoshiaki Taniyama, Jun Muratsu, et al.
Cells|August 28, 2024
Experimental Study: The Development of a Novel Treatment for Chemotherapy-Resistant Tongue Cancer with the Inhibition of the Pathological Periostin Splicing Variant 1-2 with Exon 21Shoji Ikebe, Nobutaka Koibuchi, Kana Shibata, et al.
Frontiers in Endocrinology|March 9, 2018
IGF Binding Protein-5 Induces Cell SenescenceFumihiro Sanada, Yoshiaki Taniyama, Jun Muratsu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 1, 2012
Hepatocyte growth factor inhibits lipopolysaccharide-induced oxidative stress via epithelial growth factor receptor degradationKazutaka Shimizu, Yoshiaki Taniyama, Fumihiro Sanada, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 8, 2010
[Therapeutic angiogenesis for diabetes mellitus related ischemic disease]Yoshiaki Taniyama, Fumihiro Sanada, Ryuichi Morishita
Frontiers in Cardiovascular Medicine|July 16, 2025
Targeting the hallmarks of aging: mechanisms and therapeutic opportunitiesFumihiro Sanada, Shinichiro Hayashi, Ryuichi Morishita
Hypertension (Dallas, Tex. : 1979)|August 11, 2020
Progress of Gene Therapy in Cardiovascular DiseaseMunehisa Shimamura, Hironori Nakagami, Fumihiro Sanada, et al.
Annals of Vascular Diseases|June 30, 2020
Therapeutic Angiogenesis Using HGF PlasmidFumihiro Sanada, Tatsuya Fujikawa, Kana Shibata, et al.
Scientific Reports|March 10, 2017
Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in MiceJun Muratsu, Masaaki Iwabayashi, Fumihiro Sanada, et al.
Frontiers in Cardiovascular Medicine|March 23, 2018
Source of Chronic Inflammation in AgingFumihiro Sanada, Yoshiaki Taniyama, Jun Muratsu, et al.
Medicines (Basel, Switzerland)|March 31, 2018
Gene-Therapeutic Strategies Targeting Angiogenesis in Peripheral Artery DiseaseFumihiro Sanada, Yoshiaki Taniyama, Jun Muratsu, et al.
Cells|August 28, 2024
Experimental Study: The Development of a Novel Treatment for Chemotherapy-Resistant Tongue Cancer with the Inhibition of the Pathological Periostin Splicing Variant 1-2 with Exon 21Shoji Ikebe, Nobutaka Koibuchi, Kana Shibata, et al.
Frontiers in Endocrinology|March 9, 2018
IGF Binding Protein-5 Induces Cell SenescenceFumihiro Sanada, Yoshiaki Taniyama, Jun Muratsu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 1, 2012
Hepatocyte growth factor inhibits lipopolysaccharide-induced oxidative stress via epithelial growth factor receptor degradationKazutaka Shimizu, Yoshiaki Taniyama, Fumihiro Sanada, et al.
Pageof 6